Wedbush raises CG Oncology target price to $84 from $80
CGON•Wedbush raised its target price for CG Oncology to $84 from $80.
Related News
Mentari Therapeutics names Todd Shegog to board, audit committee chair
MTRI•
Twist Bioscience participates in Jefferies, Evercore healthcare conference fireside chats
TWST•
LKQ's Salvatore Abbate assumes president and CEO roles early on Nov. 9, 2026
LKQ•
Lam Research: B. Riley cuts target price to $310 from $338
LRCX•
Hain Celestial Q1 FY27 adjusted EBITDA falls 11% year over year to $18 million
HAIN•